This role is responsible for leading the strategic direction and operations within their geographic region, as well as the cross-functional coordination, collaboration and execution to bring Apitegromab to patients and families living with SMA. This is a unique opportunity to lead strategic regional execution for the first commercial launch for Scholar Rock for the first and only muscle-targeted treatment for Spinal Muscular Atrophy (SMA).